Abstract:Vascular remodeling is being recognized as a fundamental process during atherosclerosis and restenosis. Cumulative studies have demonstrated that extracellular matrix (ECM) degrading enzymes play a critical role during vascular remodeling. A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family is a recently identified metalloproteinase family which also has capacity to degrade ECM. ADAMTS family consists of 19 members and has been linked to a variety of physiological processes including development, angiogenesis, coagulation etc. Aberrant expression or function of ADAMTS members have been implicated to many disease states such as arthritis, cancer, thrombocytopenic purpura, but barely described with regard to cardiovascular disease. This review summarizes the recent advance with respect to the role of ADAMTS-7 in vascular remodeling. We review the structure, tissue distribution, substrate, expression and regulation of ADAMTS-7, especially highlight the fine tune by ADAMTS-7 of its substrate cartilage oligomeric matrix protein (COMP) in maintaining vascular homeostasis. By use of rat carotid artery balloon injury model to mimic vascular injury in vivo, we found that ADAMTS-7 protein was accumulated preferentially in neointima and mainly localized in vascular smooth muscle cells (VSMCs). Adenovirus-elicited ADAMTS-7 overexpression greatly accelerated VSMCs migration and proliferation both in vivo and in vitro, and subsequently aggravated neointima thickening post-injury. Conversely, siRNA-mediated ADAMTS-7 knock down bona fide inhibited VSMCs migration and proliferation in cultured VSMCs and injured arteries, and ultimately ameliorated neointima area. Further studies demonstrated that ADAMTS-7 facilitated VSMCs migration through degradation of its substrate COMP. Moreover, we elucidated that COMP has the capacity to maintain the contractile phenotype of VSMCs through interacting with integrin alpha7beta1. ADAMTS-7 may therefore serve as a novel therapeutic target for atherosclerosis and postangioplasty restenosis.

Research Progress of Matrix MMP-7 in Cardiovascular Disease

Roles of matrix metalloproteinase-7 (MMP-7) in cancer

Matrix metalloproteinases involvement in pathologic conditions

The Changes of Serum Matrix Metalloproteinase-9 and Tissue Inhibitor Metalloproteinase-1 in Essential Hypertension

Research progress of role of matrix metalloproteinase 7 in tumors

Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling

Matrix metalloproteinase-9 induces cardiac fibroblast migration, collagen and cytokine secretion: Inhibition by salvianolic acid B from Salvia miltiorrhiza

The Expression of MMP-7 in Serum and Aneurysm Tissues of Patients with Abdominal Aortic Aneurysm Associated with Hypertension and the Clinical Efficacy of Endovascular Exclusion.

ADAMTS-7, a Novel Proteolytic Culprit in Vascular Remodeling.

A Role of Matrix Metalloproteinase-8 in Atherosclerosis

Prognostic Significance of Matrix Metalloproteinase 7 Immunohistochemical Expression in Colorectal Cancer: a Meta-Analysis.

Behavior of Metalloproteinases in Adipose Tissue, Liver and Arterial Wall: An Update of Extracellular Matrix Remodeling

Matrix metalloproteinase-7 promotes chronic kidney disease progression via the induction of inflammasomes and the suppression of autophagy

Matrix metalloproteases: variations on a theme

Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal

Matrix Metalloproteinase-9 and Inflammatory Reaction

Angiotensin II-induced Matrix Metalloproteinase-8 is Regulated by Angiotensin-(1-7) in Vascular Smooth Muscle Cells

An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo.

Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments

[Progress of Study on the Roles of Matrix Metalloproteinases in the Pathogenesis of Hematologic Malignancies -- Review].

Matrix metalloproteinases at a glance